Community Pharmacy Scotland has urged the Scottish government to let local pharmacies handle a national NHS service for weight loss medicines. This push comes from their manifesto released on September 2, 2025, ahead of the 2026 elections, aiming to make treatments safer and more accessible for people dealing with obesity.
Why Pharmacies Could Lead the Way
Scotland faces a growing obesity challenge, with about one in three adults affected. Community Pharmacy Scotland believes pharmacies are ideal spots to deliver weight loss drugs like tirzepatide and semaglutide. These places already handle many health services, and adding this could ease pressure on doctors and hospitals.
Experts say pharmacies offer quick access and expert advice. Patients could get injections or pills with checks on safety and progress. This setup might help more people stick to their plans, leading to better health outcomes.
The manifesto points out that pharmacies can spot early signs of related issues like diabetes. By screening and advising, they could prevent bigger problems down the line.
Details of the Proposed Service
The plan calls for a full national rollout by 2026. It would include training for pharmacists to prescribe and monitor these drugs. Funding would come from the NHS budget, with a focus on those with high BMI and health risks.
Here are key features of the suggested service:
- Easy access at local pharmacies without long waits for doctor visits.
- Regular check-ins to track weight loss and side effects.
- Links to diet and exercise support for lasting results.
- Free or low-cost options for eligible patients.
This mirrors pilots in England, where pharmacies test similar programs. Early results show higher patient satisfaction and cost savings for the health system.
Scotland’s move fits with broader UK trends. In June 2025, the NHS started offering drugs like Mounjaro to thousands, but supply issues have slowed things down.
Challenges and Criticisms
Not everyone agrees with the idea. Some doctors worry about pharmacies taking on complex cases without full medical oversight. There are concerns about drug shortages, as seen in recent months with high demand.
Public opinion is mixed. Polls from July 2025 show many younger adults support pharmacy access, but older groups prefer traditional doctor routes.
| Challenge | Potential Impact | Possible Solution |
|---|---|---|
| Drug Shortages | Delays in treatment for patients | Increase production and import options |
| Training Needs | Pharmacists require more skills | Government-funded courses starting in 2025 |
| Cost to NHS | Higher initial spending | Long-term savings from fewer obesity-related illnesses |
| Patient Safety | Risk of misuse | Strict guidelines and monitoring protocols |
These hurdles could slow the rollout, but supporters argue the benefits outweigh the risks.
Broader Impact on Public Health
Obesity costs Scotland’s NHS billions each year in treating heart disease, diabetes, and other issues. A pharmacy-led service could cut these costs by helping people lose weight earlier.
Recent data from 2025 shows weight loss drugs help users drop 10 to 20 percent of body weight on average. Combined with lifestyle changes, this reduces risks of serious conditions.
The UK government has invested 85 million pounds in pilots, including pharmacy trials set for summer 2026. Scotland could build on this to create a model for the whole nation.
Success stories from users highlight real changes. Many report better energy and confidence after starting treatment.
What Happens Next
The manifesto is part of a larger push for pharmacy roles in health care. Community Pharmacy Scotland wants talks with leaders before the 2026 vote.
If approved, the service could start small in key areas and expand. Watch for updates from health officials in the coming months.
Share your thoughts on this plan in the comments below, and pass this article along to friends who might find it useful.
